CONSeQuence: prediction of reference peptides for absolute quantitative proteomics using consensus machine learning approaches

Mass spectrometric based methods for absolute quantification of proteins, such as QconCAT, rely on internal standards of stable-isotope labeled reference peptides, or "Q-peptides," to act as surrogates. Key to the success of this and related methods for absolute protein quantification (such as AQUA) is selection of the Q-peptide. Here we describe a novel method, CONSeQuence (consensus predictor for Q-peptide sequence), based on four different machine learning approaches for Q-peptide selection. CONSeQuence demonstrates improved performance over existing methods for optimal Q-peptide selection in the absence of prior experimental information, as validated using two independent test sets derived from yeast. Furthermore, we examine the physicochemical parameters associated with good peptide surrogates, and demonstrate that in addition to charge and hydrophobicity, peptide secondary structure plays a significant role in determining peptide "detectability" in liquid chromatography-electrospray ionization experiments. We relate peptide properties to protein tertiary structure, demonstrating a counterintuitive preference for buried status for frequently detected peptides. Finally, we demonstrate the improved efficacy of the general approach by applying a predictor trained on yeast data to sets of proteotypic peptides from two additional species taken from an existing peptide identification repository.     

Production and characterization of peptide antibodies

Proteins are effective immunogens for generation of antibodies. However, occasionally the native protein is known but not available for antibody production. In such cases synthetic peptides derived from the native protein are good alternatives for antibody production. These peptide antibodies are powerful tools in experimental biology and are easily produced to any peptide of choice. A widely used approach for production of peptide antibodies is to immunize animals with a synthetic peptide coupled to a carrier protein. Very important is the selection of the synthetic peptide, where factors such as structure, accessibility and amino acid composition are crucial. Since small peptides tend not to be immunogenic, it may be necessary to conjugate them to carrier proteins in order to enhance immune presentation. Several strategies for conjugation of peptide-carriers applied for immunization exist, including solid-phase peptide-carrier conjugation and peptide-carrier conjugation in solution. Upon immunization, adjuvants such as Al(OH)(3) are added together with the immunogenic peptide-carrier conjugate, which usually leads to high-titred antisera. Following immunization and peptide antibody purification, the antibodies are characterized based on their affinity or specificity. An efficient approach for characterization of peptide antibodies is epitope mapping using peptide based assays. This review describes standard solid-phase approaches for generation of peptide antibodies with special emphasis on peptide selection, generation of peptide conjugates for immunization and characterization of the resulting peptide antibodies.     

Synthetic peptide vaccines against foot-and-mouth disease. I. Duration of the immune response and priming in guinea-pigs, rabbits and mice

The immunogenicity of two aphthovirus-specific synthetic peptides was investigated. One peptide copied the sequence of amino acids 141 to 160 from the capsid VP1 of the aphthovirus strains O1 BFS 1860 and O1 Kaufbeuren (O peptide), the other copied the equivalent sequence from aphthovirus strain A24 Cruzeiro (A peptide). Peptide coupled to keyhole limpet haemocyanin (KLH) stimulated a long-lasting immune response in guinea-pigs and rabbits. Significant levels of antibody were detectable at least one year after vaccination, although the reactivity of the antibody depended on the species and the peptide used. In some circumstances the peptides were able to prime the immune system such that a subsequent dose of peptide boosted antibody production. This effect, also, was dependent on the species of experimental animal and on the peptide used, an observation which has important implications for the use of such peptides as vaccines.     

Regulation of plant peptide hormones and growth factors by post‐translational modification

The number, diversity and significance of peptides as regulators of cellular differentiation, growth, development and defence of plants has long been underestimated. Peptides have now emerged as an important class of signals for cell‐to‐cell communication over short distances, and also for long‐range signalling. We refer to these signalling molecules as peptide growth factors and peptide hormones, respectively. As compared to remarkable progress with respect to the mechanisms of peptide perception and signal transduction, the biogenesis of signalling peptides is still in its infancy. This review focuses on the biogenesis and activity of small post‐translationally modified peptides. These peptides are derived from inactive pre‐pro‐peptides of approximately 70–120 amino acids. Multiple post‐translational modifications (PTMs) may be required for peptide maturation and activation, including proteolytic processing, tyrosine sulfation, proline hydroxylation and hydroxyproline glycosylation. While many of the enzymes responsible for these modifications have been identified, their impact on peptide activity and signalling is not fully understood. These PTMs may or may not be required for bioactivity, they may inactivate the peptide or modify its signalling specificity, they may affect peptide stability or targeting, or its binding affinity with the receptor. In the present review, we will first introduce the peptides that undergo PTMs and for which these PTMs were shown to be functionally relevant. We will then discuss the different types of PTMs and the impact they have on peptide activity and plant growth and development. We conclude with an outlook on the open questions that need to be addressed in future research.     

The N-terminal peptide of the hexon of human adenovirus type 2: its chemical synthesis and antigenic properties]

Peptides corresponding to the N-terminal section of protein of a hexone of the 2nd type human adenovirus have been synthesized. Being conjugated with a carrier of BSA they induced formation of antibodies which reacted both with peptides and with viral proteins. Sera to native proteins were also bound to synthetic peptides. Immunogenicity strengthening in peptides conjugated with synthetic polyelectrolytes is shown. The N-terminal section of hexon is supposed to participate in formation of an antigenic determinant possessing group specificity.     

Monoclonal antibodies distinguish synthetic peptides that differ in one chemical group

By using human calcitonin (hCT), human calcitonin-gene-related peptide (hCGRP), and a synthetic peptide with a sequence analogous to the 34 C-terminal amino acids of human preprocalcitonin (designated as PQN-34) as haptens in the generation of monoclonal antibodies, we assessed the role of amido and amino groups in paratope-epitope binding. By using peptide inhibition experiments and solid-phase immunoassays, monoclonal anti-hCT antibody CT07 and monoclonal anti-hCGRP antibody CGR01 were found to bind to an antigenic determinant located in the C-terminal segment of the hormones. These epitopes comprise the seven C-terminal amino acids of the hormones, and the presence of the hormone-ending carboxamide group was found to be essential for antibody binding. The corresponding heptapeptides, either bearing a carboxyl group or else linked to a glycine residue at their C-terminal part, failed to react with the antibodies. Moreover, these monoclonal antibodies did not bind to synthetic peptides analogous to the C-terminal region of the hormone precursor molecules that comprised the epitope site flanked by a peptide sequence. In an attempt to assess whether amido groups when present on the side-chain of amino acids may also modulate antibody binding, a monoclonal antibody referred to as QPO1 was produced and was found to recognize an antigenic determinant localized in the N-terminal region of the PQN-34 peptide bearing a glutamine residue as the N-terminal amino acid. The epitope was found to correspond to a topographic assembled site, and binding of QPO1 was found to be substantially dependent on the presence of the free amino and the side-chain amido groups borne by the N-terminal glutamine residue of this peptide PQN-34. In contrast to these findings, an antigenic determinant located in the internal sequence of calcitonin and recognized by monoclonal anti-hCT antibody CT08 was found to be expressed on the mature form of the hormone, as well as on synthetic peptides with sequence mimicking that of preprocalcitonin. These data should guide the choice of synthetic peptide haptens for the production of anti-protein antibodies.     

The utility of ETD mass spectrometry in proteomic analysis

Mass spectrometry has played an integral role in the identification of proteins and their post-translational modifications (PTM). However, analysis of some PTMs, such as phosphorylation, sulfonation, and glycosylation, is difficult with collision-activated dissociation (CAD) since the modification is labile and preferentially lost over peptide backbone fragmentation, resulting in little to no peptide sequence information. The presence of multiple basic residues also makes peptides exceptionally difficult to sequence by conventional CAD mass spectrometry. Here we review the utility of electron transfer dissociation (ETD) mass spectrometry for sequence analysis of post-translationally modified and/or highly basic peptides. Phosphorylated, sulfonated, glycosylated, nitrosylated, disulfide bonded, methylated, acetylated, and highly basic peptides have been analyzed by CAD and ETD mass spectrometry. CAD fragmentation typically produced spectra showing limited peptide backbone fragmentation. However, when these peptides were fragmented using ETD, peptide backbone fragmentation produced a complete or almost complete series of ions and thus extensive peptide sequence information. In addition, labile PTMs remained intact. These examples illustrate the utility of ETD as an advantageous tool in proteomic research by readily identifying peptides resistant to analysis by CAD. A further benefit is the ability to analyze larger, non-tryptic peptides, allowing for the detection of multiple PTMs within the context of one another.     

Bioactive Fragment of Human IL-1β [163-171] Modulates the Immune Response to Synthetic Peptides of HIV

The activation of T helper cells specific for viral antigens is critical for antibody production and the generation of cytotoxic T cells during retroviral infection. In this study, we examined the effect of linking HIV peptides with a bioactive fragment of human interleukin-1β (IL-1β) (163–171) on the induction of immune response to the peptides. A panel of highly purified synthetic peptides representing defined regions of gp41, Gag and gp120 were used as antigens. Mouse spleen cells primed with the peptide conjugates produced greater proliferation on in vitro stimulation than spleen cells primed with peptide alone. In addition, antibody production as assessed by ELISA was observed after immunization with conjugated peptides but not with peptide alone, indicating B-cell activation. We also found that a high level of IgG2a antibody production correlated with a high level of IFN-γ production. These findings favor the notion that IL-1β plays an important role in immune responses. These observations support the formulation and design of synthetic vaccines against HIV using synthetic HIV peptides conjugated with immunomodulators. Such an approach may provide an effective vaccination against other infectious agents.     

Epitope mapping and evaluation of specificity of T-helper sites in four major antigenic peptides of chicken riboflavin carrier protein in outbred rats

This paper reviews our studies on synthetic peptides spanning the major antigenic determinants of the chicken riboflavin carrier protein (RCP; 219 AA). These determinants are composed of residues 4-24 (YGC), 64-83 (CED), 130-147 (GEN), and 200-219 (HAC) and function as minivaccines in terms of eliciting anti-peptide antibodies which recognize the native protein and are particularly promising contraceptive vaccine candidates. We have used 15-residue synthetic peptides to define short sequences involved in interaction with antibody and with T-cells. We have mapped the boundaries of T-cell epitopes of these peptides in outbred rats by immunizing the animals with each peptide and assaying the popliteal lymph node cell proliferation against a series of overlapping synthetic 15-mers covering the entire length of the individual peptides. The peptides YGC, GEN, and HAC harboured a single T-cell epitope each whereas the peptide CED exhibited bimodal response possessing two epitopes, one at N-terminus and the other at the C-terminus. These studies provide insight into the way in which an immunogen is viewed by the immune system. In addition, preferential T-cell helper function for B cells recognizing unique determinants on the same molecule was demonstrated. This information helps in exploiting synthetic peptides in the construction of designer immunogens which have potential as candidate vaccines.     

Preparative peptide isoelectric focusing as a tool for improving the identification of lysine-acetylated peptides from complex mixtures

Protein sequence database searching of tandem mass spectrometry data is commonly employed to identify post-translational modifications (PTMs) to peptides in global proteomic studies. In these studies, the accurate identification of these modified peptides relies on strategies to ensure high-confidence results from sequence database searching in which differential mass shift parameters are employed to identify PTMs to specific amino acids. Using lysine acetylation as an example PTM, we have observed that the inclusion of differential modification information in sequence database searching dramatically increases the potential for false-positive sequence matches to modified peptides, making the confident identification of true sequence matches difficult. In a proof-of-principle study of whole cell yeast lysates, we demonstrate the combination of preparative isoelectric focusing using free-flow electrophoresis, and an adjusted peptide isoelectric point prediction algorithm, as an effective means to increase the confidence of lysine-acetylated peptide identification. These results demonstrate the potential utility of this general strategy for improving the identification of PTMs which cause a shift to the intrinsic isoelectric point of peptides.     

A synthetic peptide corresponding to the phosphorylcholine (PC)-binding region of human C-reactive protein possesses the TEPC-15 myeloma PC-idiotype.

C-reactive protein (CRP) is a major acute phase reactant in most mammalian species. CRP molecules from all species display Ca2(+)-dependent binding to phosphorylcholine (PC). The conserved PC-binding region of CRP corresponds to amino acids 51-66 within the human CRP sequence. A synthetic peptide composed of residues 47-63 of human CRP was previously shown to possess PC binding activity. The charged amino acids at positions 57, 58, 60, and 62 of this synthetic peptide were critical for PC-binding based on lower binding activity of synthetic peptides containing uncharged residues at these positions. The PC-binding peptide was used to generate mouse mAb that were tested for reactivity with intact CRP and with the TEPC-15 (T-15) mouse myeloma protein that also binds PC. The PC-binding peptide of CRP was recognized by two mAb specific for the T-15 Id. One of the mAb generated against the PC-binding peptide of CRP (IID6.2) recognized an epitope on the T-15 protein that was also recognized by the near-binding site-specific mAb (F6) to the T-15 PC-Id. Binding of IID6.2 to T-15 myeloma protein was not inhibited by PC and did not require Ca2+; however, binding was inhibited by the synthetic PC-binding peptide itself. Recognition of synthetic peptides containing uncharged amino acid substitutions by mAb F6 and IID6.2 was greatly reduced indicating that the shared epitope on T-15 and CRP was composed of similar charged residues. Therefore, CRP displays the same idiotope as an antibody that shares its specificity for the hapten, PC.     

EpiProfile Quantifies Histone Peptides With Modifications by Extracting Retention Time and Intensity in High-resolution Mass Spectra

Histone post-translational modifications contribute to chromatin function through their chemical properties which influence chromatin structure and their ability to recruit chromatin interacting proteins. Nanoflow liquid chromatography coupled with high resolution tandem mass spectrometry (nanoLC-MS/MS) has emerged as the most suitable technology for global histone modification analysis because of the high sensitivity and the high mass accuracy of this approach that provides confident identification. However, analysis of histones with this method is even more challenging because of the large number and variety of isobaric histone peptides and the high dynamic range of histone peptide abundances. Here, we introduce EpiProfile, a software tool that discriminates isobaric histone peptides using the distinguishing fragment ions in their tandem mass spectra and extracts the chromatographic area under the curve using previous knowledge about peptide retention time. The accuracy of EpiProfile was evaluated by analysis of mixtures containing different ratios of synthetic histone peptides. In addition to label-free quantification of histone peptides, EpiProfile is flexible and can quantify different types of isotopically labeled histone peptides. EpiProfile is unique in generating layouts (i.e. relative retention time) of histone peptides when compared with manual quantification of the data and other programs (such as Skyline), filling the need of an automatic and freely available tool to quantify labeled and non-labeled modified histone peptides. In summary, EpiProfile is a valuable nanoflow liquid chromatography coupled with high resolution tandem mass spectrometry-based quantification tool for histone peptides, which can also be adapted to analyze nonhistone protein samples.The nucleosome, the basic unit of chromatin, consists of 147 base pairs of DNA wrapped around histone proteins (H2A, H2B, H3, and H4). Histones play vital roles in chromatin, interacting with many signaling proteins and chromatin-structural proteins through various post-translational modifications (PTMs)¹ (1–3). There are numerous PTMs on histones, including methylation (mono - me1, di - me2, tri - me3), acetylation (ac), phosphorylation (ph), ubiquitination, and SUMOylation (4). Histone PTMs can affect chromatin function, and therefore influence processes such as gene accessibility, DNA repair and chromosome condensation. Moreover, histone PTMs cross-talk in a synergistic manner to fine-tune gene expression (5). Therefore, quantification of histone PTMs has become a high priority to investigate cell regulation and epigenetics (6).Traditionally, antibody-based methods (e.g. Western blot) have been used to analyze histone modifications (7), which have multiple disadvantages. First, antibodies are not available for every new PTM discovered. Second, PTMs on neighboring amino acids (e.g. H3K9me1–3 and H3S10ph) may prevent antibody binding, a phenomenon called epitope occlusion. Third, the quantification of PTMs via antibody-based methods is not sensitive to small differences (e.g. <twofold). Mass spectrometry (MS) has emerged as a sensitive and efficient technique to detect known and novel PTMs (8). The high mass accuracy and the high speed of modern mass spectrometers allow for sensitive, confident, and accurate peptide quantification when coupled with nanoflow liquid chromatography (nanoLC).NanoLC-MS/MS analysis of protein digests (i.e. bottom-up MS) is nowadays a mature and widely applied technology. Data-dependent acquisition is the most commonly adopted MS acquisition method to identify peptides via bottom-up MS (9–12), generating MS1 and MS2 spectra. Nevertheless, histone proteins are particularly challenging to analyze by using the generalized bottom-up workflow. As histones are rich with lysines and arginines, tryptic digest of histones generates short peptides that are difficult to be retained on C18 columns. To improve histone peptide retention, the unmodified and mono-methylated lysines and peptide N terminus can be selectively chemically propionylated (13–16), preventing tryptic digest after lysine to generate longer peptides. Moreover, peptide identification through traditional database searches leads to a large number of false positives, as allowing several dynamic modifications (e.g. me1/me2/me3, ac, ph) dramatically increases the number of molecular candidates and thus the possibility to achieve a false hit (12). Therefore, software tools that quantify histone peptides require additional data to correctly map a given peptide, such as previous knowledge of peptide retention time.Quantification of histone peptides is particularly challenging because of presence of isobaric peptides, near isobaric PTMs such as tri-methylation (42.047 Da) and acetylation (42.011 Da), and low abundant species. Previous knowledge about relative peptide retention time (RT) enables differentiation between species close in mass and therefore selection of the correct peak for integration of the area of the chromatographic peak (i.e. area under curve or AUC). However, determination of peptide RT might be difficult because of their low abundance though acid extraction was performed to purify histones. This problem can be solved by using isotopically labeled synthetic histone peptides (17), or data independent approaches (18). When using relative retention time information to assign peak identities, reproducible nanoLC is crucial, especially because some isobaric peptides co-elute. In this case, the MS acquisition method must perform targeted MS2 for the co-eluting isobaric peptides at the specific time that they elute. These species can be discriminated and quantified based on the intensity of fragment ions unique to each species. For instance, the peptides KacSTGGKAPR (H3K9ac) and KSTGGKacAPR (H3K14ac) have the same mass and overlap at the nanoLC elution (the full protein sequence of human canonical histone H3 and H4 are shown in Fig. 1A). Thus, the co-eluting isobaric peptides could not be quantified separately based on the MS1 signal, but the unique fragment ions present in MS2 spectra allow them to be quantified individually.Open in a separate windowFig. 1.Histones are a challenge for quantitative mass spectrometry analyses. A, Human histone H3.1 and H4 protein sequences. B, Spline fitting to calculate AUC: blue lines are the original peaks and pink lines are the fitted peaks. C, An example of isobaric PTM modified peptides. The above MS2 is matched with H3K18ac, and the same MS2 is also matched with H3K23ac below. D, The workflow of EpiProfile: inputting precursor m/z and charge state, extracting elution profiles, selecting the correct chromatographic peak, calculating AUC, and outputting quantification tables and figures.There have been few computational investigations attempting to solve the problem of quantifying co-eluting isobaric peptides. DiMaggio et al. used a mixed integer linear optimization (MILP) framework to quantify partially co-eluting isobaric histone peptides from electron transfer dissociation (ETD) spectra (19). The framework is comprised of two MILP models: (1) enumerating the entire space of the modified forms that satisfy a given peptide mass and (2) determining the relative composition of the modified forms in the spectrum. Another study by Guan et al. identified isobaric peptides by searching ETD MS/MS spectra for ions representing all possible configurations of modified peptides using a visual assistance program. The relative abundances of these species were estimated by using a nonnegative least squares procedure (20). Other quantification programs can also perform accurate peak picking, but are commonly not as suitable for heavily modified and isobaric histone peptides (e.g. Skyline) (21). These software programs are unable to provide the layouts of histone peptides (i.e. relative RTs) or discriminate all isobaric modified peptides, two tasks that are vital for full characterization of a histone sample.In this study, we developed a new quantification program named EpiProfile. EpiProfile extracts ion chromatography for known histone peptides by using previous knowledge about their elution profiles. Moreover, it discriminates and quantifies the isobaric histone peptides by resolving the linear equations listed with the peak heights of unique fragment ions between the two modification sites in the MS2 spectra (e.g. ions between H3K9ac and H3K14ac). We evaluated the accuracy of EpiProfile by mixing different ratios of synthetic histone peptides, and then tested EpiProfile by analyzing nanoLC-MS/MS data sets of the following samples: purified histones from HeLa cells, a synthetic histone peptide library, and histone peptides labeled during cell growth with ¹³C-labeled glucose media or stable isotope labeling by amino acids in cell culture (SILAC) (22). We compared EpiProfile to manual quantification of the data, and also with the openly available program Skyline. We found that manual quantification is obviously time-consuming and that Skyline cannot generate the layouts of histone peptides and cannot discriminate four or six-component isobaric peptides, a common occurrence in histone data. Moreover, EpiProfile is highly flexible, and thus it can be used to analyze various protein samples, including isotopically labeled peptides and nonhistone data sets.     

Identification and characterization of Ch806 mimotopes

The chimeric antibody 806 (Ch806) is a promising antitumor agent that recognizes both the epidermal growth factor receptor variant III (EGFRvIII) and the overexpressed epidermal growth factor receptor (EGFR) in cancer tissues but does not recognize the wild type EGFR in normal tissues. However, passive antibody immunization could not produce effective antitumor titers unless the immunization was administered repeatedly over long periods. To overcome this limitation, we generated epitope mimics that bind to Ch806 and tested whether the peptide mimics could induce the production of similar antibodies when actively immunizing mice with the peptides. We used the PH.D-12 phage display peptide library to identify peptides that bind to the monoclonal antibody (mAb) 12H23, which also recognizes similar epitopes of Ch806. Two mimotopes (WHTEILKSYPHE and LPAFFVTNQTQD) were shown to mimic the mAb 12H23 and Ch806 epitope using immunoassays. The mimotopes were conjugated to immunogenic carrier proteins and used to intraperitoneally immunize BALB/c mice. Interestingly, sera from the mice immunized with the isolated mimotopes not only recognize the recombinant or synthetic 806 eptitope, but can also recognize EGFR that is overexpressed in A431 cells and EGFRvIII expressed in Huh7-EGFRvIII cells, whereas sera from mice immunized with the control peptide-KLH (keyhole limpet hemocyanin) and carrier KLH alone failed to show a similar reactivity. Furthermore, in an antibody-dependent cellular cytotoxicity assay (ADCC), the mimotope-induced antibodies specifically lysed human Huh-7-EGFRvIII cells. Our data indicate that the isolated mimotopes reported here may potentially be used as new alternative agents for treating cancer with EGFRvIII expression or EGFR overexpression.     

Post-translational Modification of LipL32 during Leptospira interrogans Infection

Background

Leptospirosis, a re-emerging disease of global importance caused by pathogenic Leptospira spp., is considered the world''s most widespread zoonotic disease. Rats serve as asymptomatic carriers of pathogenic Leptospira and are critical for disease spread. In such reservoir hosts, leptospires colonize the kidney, are shed in the urine, persist in fresh water and gain access to a new mammalian host through breaches in the skin.

Methodology/Principal Findings

Previous studies have provided evidence for post-translational modification (PTM) of leptospiral proteins. In the current study, we used proteomic analyses to determine the presence of PTMs on the highly abundant leptospiral protein, LipL32, from rat urine-isolated L. interrogans serovar Copenhageni compared to in vitro-grown organisms. We observed either acetylation or tri-methylation of lysine residues within multiple LipL32 peptides, including peptides corresponding to regions of LipL32 previously identified as epitopes. Intriguingly, the PTMs were unique to the LipL32 peptides originating from in vivo relative to in vitro grown leptospires. The identity of each modified lysine residue was confirmed by fragmentation pattern analysis of the peptide mass spectra. A synthetic peptide containing an identified tri-methylated lysine, which corresponds to a previously identified LipL32 epitope, demonstrated significantly reduced immunoreactivity with serum collected from leptospirosis patients compared to the peptide version lacking the tri-methylation. Further, a subset of the identified PTMs are in close proximity to the established calcium-binding and putative collagen-binding sites that have been identified within LipL32.

Conclusions/Significance

The exclusive detection of PTMs on lysine residues within LipL32 from in vivo-isolated L. interrogans implies that infection-generated modification of leptospiral proteins may have a biologically relevant function during the course of infection. Although definitive determination of the role of these PTMs must await further investigations, the reduced immune recognition of a modified LipL32 epitope suggests the intriguing possibility that LipL32 modification represents a novel mechanism of immune evasion within Leptospira.     

Functional peptide microarrays for specific and sensitive antibody diagnostics

Peptide microarrays displaying biologically active small synthetic peptides in a high-density format provide an attractive technology to probe complex samples for the presence and/or function of protein analytes. We present a new approach for manufacturing functional peptide microarrays for molecular immune diagnostics. Our method relies on the efficiency of site-specific solution-phase coupling of biotinylated synthetic peptides to NeutrAvidin (NA) and localized microdispensing of peptide-NA-complexes onto activated glass surfaces. Antibodies are captured in a sandwich manner between surface immobilized peptide probes and fluorescence-labeled secondary antibodies. Our work includes a total of 54 peptides derived from immunodominant linear epitopes of the T7 phage capsid protein, Herpes simplex virus glycoprotein D, c-myc protein, and three domains of the Human coronavirus polymerase polyprotein and their cognate mAbs. By using spacer molecules of different type and length for NA-mediated peptide presentation, we show that the incorporation of a minimum spacer length is imperative for antibody binding, whereas the peptide immobilization direction has only secondary importance for antibody affinity and binding. We further demonstrate that the peptide array is capable of detecting low-picomolar concentrations of mAbs in buffered solutions and diluted human serum with high specificity.     

A validated antibody panel for the characterization of tau post-translational modifications

Background

Tau is a microtubule-binding protein, which is subject to various post-translational modifications (PTMs) including phosphorylation, methylation, acetylation, glycosylation, nitration, sumoylation and truncation. Aberrant PTMs such as hyperphosphorylation result in tau aggregation and the formation of neurofibrillary tangles, which are a hallmark of Alzheimer’s disease (AD). In order to study the importance of PTMs on tau function, antibodies raised against specific modification sites are widely used. However, quality control of these antibodies is lacking and their specificity for particular modifications is often unclear.

Methods

In this study, we first designed an online tool called ‘TauPTM’, which enables the visualization of PTMs and their interactions on human tau. Using TauPTM, we next searched for commercially available antibodies against tau PTMs and characterized their specificity by peptide array, immunoblotting, electrochemiluminescence ELISA and immunofluorescence technologies.

Results

We demonstrate that commercially available antibodies can show a significant lack of specificity, and PTM-specific antibodies in particular often recognize non-modified versions of the protein. In addition, detection may be hindered by other PTMs in close vicinity, complicating the interpretation of results. Finally, we compiled a panel of specific antibodies and show that they are useful to detect PTM-modified endogenous tau in hiPSC-derived neurons and mouse brains.

Conclusion

This study has created a platform to reliably and robustly detect changes in localization and abundance of post-translationally modified tau in health and disease. A web-based version of TauPTM is fully available at http://www.tauptm.org.

     

A single 10-residue pre-S(1) peptide can prime T cell help for antibody production to multiple epitopes within the pre-S(1), pre-S(2), and S regions of HBsAg

The purpose of this study was to identify and characterize T cell and B cell recognition sites within the pre-S(1) region of HBsAg/p43, and to then analyze functional T cell-B cell interactions at the level of in vivo antibody production. The results indicate: three peptide sequences within the pre-S(1) region of HBsAg were identified which can induce and elicit HBsAg/p43-specific T cell proliferation; a 10-amino acid peptide, p12-21, defines one pre-S(1)-specific T cell recognition site, and residues 18 and 19 are critical to the recognition process; the p12-21 sequence can function as a T cell carrier for a synthetic B cell epitope within the pre-S(2) region; the p94-117 sequence contains at least two T cell recognition sites; five distinct, pre-S(1)-specific antibody binding sites were identified; synthetic pre-S(1) region T cell determinants can prime in vivo antibody production to multiple B cell epitopes within the pre-S(2) and S regions, as well as within the pre-S(1) region; the specificity of the primed T cell population can influence the specificity of the B cell response; and T cell recognition of pre-S(1) region peptides is regulated by H-2-linked genes.     

Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance

Host-defence peptides secreted from the skin glands of Australian frogs and toads, are, with a few notable exceptions, different from those produced by anurans elsewhere. This review summarizes the current knowledge of the following classes of peptide isolated and characterized from Australian anurans: neuropeptides (including smooth muscle active peptides, and peptides that inhibit the production of nitric oxide from neuronal nitric oxide synthase), antimicrobial and anticancer active peptides, antifungal peptides and antimalarial peptides. Other topics covered include sex pheromones of anurans, and the application of peptide profiling to (i). recognize particular populations of anurans of the same species and to differentiate between species, and (ii). investigate evolutionary aspects of peptide formation.     

Sequential Window Acquisition of all Theoretical Mass Spectra (SWATH) Analysis for Characterization and Quantification of Histone Post-translational Modifications

Histone post-translational modifications (PTMs) have a fundamental function in chromatin biology, as they model chromatin structure and recruit enzymes involved in gene regulation, DNA repair, and chromosome condensation. High throughput characterization of histone PTMs is mostly performed by using nano-liquid chromatography coupled to mass spectrometry. However, limitations in speed and stochastic sampling of data dependent acquisition methods in MS lead to incomplete discrimination of isobaric peptides and loss of low abundant species. In this work, we analyzed histone PTMs with a data-independent acquisition method, namely SWATH™ analysis. This approach allows for MS/MS-based quantification of all analytes without upfront assay development and no issues of biased and incomplete sampling. We purified histone proteins from human embryonic stem cells and mouse trophoblast stem cells before and after differentiation, and prepared them for MS analysis using the propionic anhydride protocol. Results on histone H3 peptides verified that sequential window acquisition of all theoretical mass spectra could accurately quantify peptides (<9% average coefficient of variation, CV) over four orders of magnitude, and we could discriminate isobaric and co-eluting peptides (e.g. H3K18ac and H3K23ac) using MS/MS-based quantification. This method provided high sensitivity and precision, supported by the fact that we could find significant differences for remarkably low abundance PTMs such as H3K9me2S10ph (relative abundance <0.02%). We performed relative quantification for few sample peptides using different fragment ions and observed high consistency (CV <15%) between the fragments. This indicated that different fragment ions can be used independently to achieve the same peptide relative quantification. Taken together, sequential window acquisition of all theoretical mass spectra proved to be an easy-to-use MS acquisition method to perform high quality MS/MS-based quantification of histone-modified peptides.Chromatin is a highly organized and dynamic entity in cell nuclei, mostly composed of DNA and histone proteins. Its structure directly influences gene expression, DNA repair, and cell duplication events such as mitosis and meiosis (1). Histones are assembled in octamers named nucleosomes, wrapped by DNA every ∼200 base pairs. Histones are heavily modified by dynamic post-translational modifications (PTMs)¹, which affect chromatin structure because of their chemical properties and their ability to recruit chromatin modifier enzymes and binding proteins (2). Moreover, histone PTMs can be inherited through cell division and thus are crucial components of epigenetic memory (3). The function of histone PTMs has been extensively studied in the last 15–20 years, and several links have been found between aberrations of histone PTM levels and development of diseases (4, 5). Such discoveries revealed the importance of histone PTMs in fine-tuning cell phenotype. Because of this, technology has been rapidly evolving to investigate histone PTM relative abundance with higher accuracy and throughput.Mass spectrometry (MS)-based strategies have continuously evolved toward higher throughput and flexibility, allowing not only identification and quantification of single histone PTMs, but also their combinatorial patterns and even characterization of the intact proteins (reviewed in (6, 7)). For histone analysis, a widely adopted workflow for nano-liquid chromatography–tandem mass spectrometry (nLC-MS/MS) includes derivatization of lysine residue side chains with propionic anhydride, proteolytic digestion with trypsin, and subsequent derivatization of peptide N termini (8, 9). Such protocol leads to generation of ArgC-like peptides (only cleaved after arginine residues) after digestion. Moreover, propionylation of N termini increases peptide hydrophobicity, thereby improving LC retention of shorter ones, and thus the MS signal. Because of the high mass accuracy, sensitivity, and the possibility to perform label-free quantification MS has become the technique of choice, outperforming antibody-based strategies, to study both known and novel global histone PTMs.Several acquisition methods have been developed for MS analysis to accomplish different needs of identification and quantification (10). The most widely adopted in shotgun or discovery proteomics is the data-dependent acquisition (DDA) mode. Such acquisition method does not require any previous knowledge about the analyte, as it automatically selects precursor ions detectable at the full scan level in a given order (commonly from the most intense) to perform MS/MS fragmentation (11). Label-free quantification is performed at the full MS scan level by integrating the area of the LC peak from an extracted ion chromatogram of the precursor mass corresponding to the given peptide. On the other hand, the selected reaction monitoring (SRM) mode is the most widely used acquisition method in targeted proteomics. Such method performs cyclic precursor ion selection, MS/MS fragmentation, and product ion selection of a list of masses input by the user. Even though the method preparation is intuitively more complex than DDA, SRM is highly popular because of the high selectivity and sensitivity, which leads to more accurate label-free quantification (12). However, both methods have inevitable drawbacks; a DDA approach cannot perform accurate quantification of isobaric and co-eluting peptides, for example, KacQLATKAAR and KQLATKacAAR (histone H3 aa 9–17), as the fragment ions should be monitored through the entire peptide peak elution to define the ratio between the two similar analytes. On the contrary, an SRM experiment prevents future data mining of unpredicted peptides, and thus such method cannot be used for any classical PTM discovery. Therefore, LC-MS/MS analysis of histone peptides is commonly performed by integrating shotgun and targeted acquisition within the same MS method (13). This method requires previous knowledge about retention time and mass of co-eluting isobaric species, and tedious manual peak integration or dedicated software to deconvolute such complex raw data. Although this mixed MS mode is a powerful approach, the targeted sequences in the method reduce the duty cycle and number of DDA MS/MS spectra that can be acquired, making it far from ideal.Data independent acquisition (DIA) modes are a third option that recently gained popularity in proteomics (14, 15). Sequential window acquisition of all theoretical mass spectra (SWATH™)-MS is a data independent workflow that uses a first quadrupole isolation window to step across a mass range, collecting high resolution full scan composite MS/MS at each step and generating an ion map of fragments from all detectable precursor masses (15, 16). From such data set, a virtual SRM, or pseudo-SRM, can be performed by extracting the product ion chromatogram of a given peptide (17) with bioinformatics tools such as Peakview®, Skyline (18), or OpenSWATH™ (19). In order to define which fragment masses should be used to quantify a given peptide, a spectral library of identified peptides can be manually programmed, downloaded (if available), or generated by previous DDA experiments. In terms of quantification power, SWATH™ combines the advantages of both DDA and SRM, as it allows for MS/MS-based label-free quantification, discrimination of isobaric peptides, and subsequent data mining of unpredicted species.Histone proteins are an excellent target sample to test SWATH™, as the peptides are heavily modified by PTMs and often have isobaric proteoforms present. We analyzed with both DDA and SWATH™ two model systems: (1) extracted histones from untreated (pluripotent) and retinoic acid (RA) treated (differentiated) human embryonic stem cells (hESCs, strain H9), and (2) extracted histones from undifferentiated and differentiated mouse trophoblast stem cells (mTSCs). The results from the DDA experiment were used to evaluate the reproducibility of peptide retention time and the variety of species identified. For the SWATH™ analysis we focused on histone H3, as it is the histone with the highest variety of modified peptides (6). Results highlighted that such acquisition method provides sensitive and precise MS/MS-based quantification of both isobaric and nonisobaric peptides. Our data demonstrate that quantification at the MS/MS level is highly reproducible, and identification of the peptide elution profile is assisted by the high mass accuracy and the large number of overlapping elution profiles of the fragment ions. Moreover, we show that by using different fragment ions for MS/MS quantification we achieved similar quantification results. Thus, we used all unique fragment ions for a given species to provide a robust quantification method, where by unique is intended fragment ions that belong to only one of the possible isobaric peptide proteoforms. Taken together, we prove that SWATH™-MS is a reliable and simple-to-use acquisition method to perform epigenetic histone PTM analysis.     

Producing peptide arrays for epitope mapping by intein-mediated protein ligation

Peptide arrays are increasingly used to define antibody epitopes and substrate specificities of protein kinases. Their use is hampered, however, by ineffective and variable binding efficiency of peptides, which often results in low sensitivity and inconsistent results. To overcome these limitations, we have developed a novel method for making arrays of synthetic peptides on various membranes after ligating the peptide substrates to an intein-generated carrier protein. We have conducted screening for optimal carrier proteins by immunoreactivity and direct assessment of binding using a peptide derivatized at a lysine sidechain with fluorescein, CDPEK(fluorescein)DS. Ligation of a synthetic peptide antigen to a carrier protein, HhaI methylase, resulted in an improved retention of peptides and an increased sensitivity of up to 10(4)-fold in immunoassay- and epitope-scanning experiments. Denaturing the ligation products with 2% sodium dodecyl sulfate (SDS) or an organic solvent (20% methanol) prior to arraying did not significantly affect the immunoreactivity of the HhaI methylase-peptide product. Because the carrier protein dominates the binding of ligation products and contains one peptide reactive site, the amount of peptide arrayed onto the membranes can be effectively normalized. This technique was utilized in the alanine scanning of hemagglutinin (HA) antigen using two monoclonal antibodies, resulting in distinguishing the different antigen epitope profiles. Furthermore, we show that this method can be used to characterize the antibodies that recognize phosphorylated peptides. This novel approach allows for synthetic peptides to be uniformly arrayed onto membranes, compatible with a variety of applications.